Program Description:
Articles of note reviewed by our cardiology experts address the pros and cons of vorapaxar in secondary prevention of atherothrombotic events; cangrelor for pre-CABG platelet inhibition; optimal serum potassium levels in myocardial infarction (MI); predictors of residual cardiovascular risk in post ACS-patients; long-term prognostic implications of procedure-related vs. spontaneous MI in patients with non-ST-elevation ACS; sex- and age-related differences in clinical presentation and in-hospital mortality in MI; and whether use of proton pump inhibitors affects outcomes in patients treated with clopidogrel.
INTENDED AUDIENCE:
Cardiologists, Primary Care Physicians
Activity Objectives:
After taking part in this educational activity, participants should be better able to:
- Discuss current approaches to the management of patients with acute coronary syndrome (ACS), particularly those undergoing percutaneous coronary intervention (PCI)
- Review the current guidelines of the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions regarding use of dual antiplatelet therapy to prevent myocardial infarction (MI) and death in patients following PCI
- Describe the concept of thienopyridine “resistance,” and explain its potential implications for secondary prevention in patients post-ACS
- Evaluate emerging options for antiplatelet therapy post-ACS, including new thienopyridines, non-thienopyridines, and other agents, taking into consideration their safety, efficacy, and mechanisms of action
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
2.00
|
AMA PRA Category 1 Credit(s)TM
|
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine of Yeshiva University and Haymarket Medical Education. Albert Einstein College of Medicine of Yeshiva University is accredited by the ACCME to provide continuing medical education for physicians.
|
Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Faculty:
PROGRAM CHAIR
James A. de Lemos, MD
Professor of Medicine
Cardiology Division
Southwestern Medical School
UT Southwestern Medical Center
Dallas, TX
EDITORIAL BOARD
Jarett D. Berry, MD
Assistant Professor, Internal Medicine-Cardiology
Southwestern Medical School
Cardiology Division
UT Southwestern Medical Center
Dallas, TX
Robert P. Giugliano, MD, SM, FACC, FAHA
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Medicine
Brigham and Women’s Hospital
Associate Professor in Medicine
Harvard Medical School
Boston, MA
CME COURSE ADVISOR
E. Scott Monrad, MD
Professor of Clinical Medicine
Albert Einstein College of Medicine
Director, Cardiac Catheterization Laboratory
Einstein Division, Montefiore Medical Center
Bronx, NY
Disclosures:
James A. de Lemos, MD, has received speakers’ honoraria from sanofi-aventis-Bristol-Myers Squibb partnership; consulting fees from AstraZeneca; and research grants from Roche Diagnostics.
Jarett D. Berry, MD, has received speakers’ honoraria from Merck/Schering.
Robert P. Giugliano, MD, SM, FACC, FAHA, has received research support from Daiichi Sankyo and Merck and lecture honoraria from Bristol-Myers Squibb, Merck, and sanofi-aventis. He is a consultant for Daiichi Sankyo, Merck, Ortho-McNeil, Regeneron, and sanofi-aventis. Dr. Giugliano is on the data safety monitoring board for Angel Med and on the clinical end point committee for Novo Nordisk.
Accreditor Disclosures
E. Scott Monrad, MD, has no relevant relationships to disclose.
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose relative to this CME activity.
Publishing Staff Disclosures
Jill Rovitzky Black, Melissa Johnson, and Anne Bardsley, Haymarket Medical Education, have nothing to disclose with regard to commercial support.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine of Yeshiva University, Daiichi Sankyo, Inc., Lilly USA, LLC, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine of Yeshiva University, Daiichi Sankyo, Inc., Lilly USA, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you have any questions relating to the accreditation of this activity, please contact Mildred Adighiuzor at 718-920-6674.
Accredited Provider:
Sponsored by Albert Einstein College of Medicine of Yeshiva University
Commercial Supporter:
Supported by an educational grant from Daiichi Sankyo, Inc., and Lilly USA, LLC.
Produced by Haymarket Medical Education
Instructions:
To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
Privacy Policy
To view the myCME privacy policy, please click here.
To view the privacy policy for Albert Einstein College of Medicine of Yeshiva University and Montefiore, please click here.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.